Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial.

about

Herbal Components of a Novel Formula PSORI-CM02 Interdependently Suppress Allograft Rejection and Induce CD8+CD122+PD-1+ Regulatory T Cells.

P2860

Q50329999-9269BFA8-155C-4744-9081-02E2273C4559

P2860

Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial.

Item

http://www.wikidata.org/entity/Q47151628

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Oral Chinese herbal medicine f ...... y, multicentre clinical trial.

@en

Oral Chinese herbal medicine f ...... y, multicentre clinical trial.

@nl

type

Item

label

Oral Chinese herbal medicine f ...... y, multicentre clinical trial.

@en

Oral Chinese herbal medicine f ...... y, multicentre clinical trial.

@nl

prefLabel

Oral Chinese herbal medicine f ...... y, multicentre clinical trial.

@en

Oral Chinese herbal medicine f ...... y, multicentre clinical trial.

@nl

P1476

Oral Chinese herbal medicine f ...... y, multicentre clinical trial.

@en

P2093

Chuanjian Lu

http://www.w3.org/2001/XMLSchema#string

Danni Yao

http://www.w3.org/2001/XMLSchema#string

Hao Deng

http://www.w3.org/2001/XMLSchema#string

Huimei Wu

http://www.w3.org/2001/XMLSchema#string

Jingwen Deng

http://www.w3.org/2001/XMLSchema#string

Yuhong Yan

http://www.w3.org/2001/XMLSchema#string

Ziyang He

http://www.w3.org/2001/XMLSchema#string

P2860

The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials

Global epidemiology of psoriasis: a systematic review of incidence and prevalence

Topical herbal formulae in the management of psoriasis: systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs.

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

Plant extracts for the topical management of psoriasis: a systematic review and meta-analysis.

Chinese medicine combined with calcipotriol betamethasone and calcipotriol ointment for Psoriasis vulgaris (CMCBCOP): study protocol for a randomized controlled trial.

Topical herbal medicine combined with pharmacotherapy for psoriasis: a systematic review and meta-analysis.

Genetic and epigenetic basis of psoriasis pathogenesis.

Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: a systematic review.

Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial.

P304

e014475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2016-014475

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zehuai Wen

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29101128

http://www.w3.org/2001/XMLSchema#string

P932

5695474

http://www.w3.org/2001/XMLSchema#string

Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial.

about

P2860

P2860

Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932